BIOLOGY 2
RUNNING HEAD: BIOLOGY 1
Student`s Name:
Professor`s Name:
Institutional Affiliation
Date:
Answers
B
C
A
B
C
C
A
C
A
A
Explanation:
The discovery is thought to replace the malfunctioning genes with a new normal functioning gene thus restoring the cells back to their normal functioning state.
The finding will help in the determination of a better and more precise treatment combination that will help in cancer cell obliteration and death.
This finding will help in the assessment of the risks associated with tobacco smoking which aims in the reduction of the risk associated with cancer.
This vector, when introduced in the body, will lead to the replacement of the mutant gene (HER2) which will result in the cell functioning normally because the gene introduced is normal and will be healthy and functioning normally.
Introduction of these antibodies elicits an immune reaction which will destroy the malignant lymphocytes.
The discovered drug ( vemurafenib) when it binds to the malignant cells it will lead to the inactivation of the BRAF gene thus any cell which contains this gene will go cell death thus destructing the cancer cells.
This finding aims to make avobenzone more stable, and thus it will absorb more harmful UV radiations, and thus the risk of skin cancer will be reduced due to the reduction in one of its risk factors.
This is because nanoparticle-sized spheres carrying the toxin will eventually destroy the tumor cells without affecting the normal cells hence destruction of cancer cells.
This finding purposes to make people understand and reduce the consumption of red meat which has been discovered to be a risk factor for colorectal cancer and thus by reducing the consumption the risk of developing cancer will decrease.
The finding aids in reducing the risk of having cancer this is because of the introduction of healthy genes which do not allow mutant genes which cause cancer to develop. What the gene also results in mutant cells is normal.
References
Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. H., … & Jemal, A. (2016). Cancer treatment and survivorship statistics, 2016. CA: a cancer journal for clinicians, 66(4), 271-289.
Croce, C. M., Liu, C. G., Calin, G. A., & Sevignani, C. (2017). U.S. Patent Application No. 15/237,396.